LITS

#4391
Lite Strategy, Inc. - Common Stock
1.0 0 USD
+0.01%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
0.98
1.00
Jahresspanne
0.69
3.23
Tagesänderung
+1.01%
Monatliche Änderung
+3.09%
6 month change
-7.41%
Jahresänderung
-66.44%
Vorheriger Schlusskurs
0.9 9
Open
0.9 9
Tief
0.9 8
Hoch
1.0 0
Volumen
13
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden Documents

2026

Current report, Q3 FY2026
Lite Strategy, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
Lite Strategy, Inc. current report, Q3 FY2026
8-K
Current report, Q2 FY2026
Lite Strategy, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q3 FY2026
Lite Strategy, Inc. quarterly report, Q3 FY2026
10-Q
Current report, Q1 FY2026
Lite Strategy, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Lite Strategy, Inc. current report, Q1 FY2026
8-K

2025

Quarterly report, Q2 FY2025
Lite Strategy, Inc. quarterly report, Q2 FY2025
10-Q
Current report, Q4 FY2025
Lite Strategy, Inc. current report, Q4 FY2025
8-K
Current report, Q4 FY2025
Lite Strategy, Inc. current report, Q4 FY2025
8-K
Current report, Q4 FY2025
Lite Strategy, Inc. current report, Q4 FY2025
8-K

Lite Strategy, Inc. current report, Q1 FY2026

Full document

Lite Strategy, Inc. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K covers events occurring on February 12, 2026, specifically the Fiscal 2026 Annual Meeting of Stockholders for Lite Strategy, Inc. (Nasdaq: LITS). The filing details the outcomes of shareholder votes and the activation of a new equity compensation plan.

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and equity plan approvals rather than financial performance metrics.

Material Changes and Corporate Actions

  • Equity Plan Approval: Stockholders approved the 2026 Omnibus Equity Compensation Plan, which became effective immediately. This approval satisfied a contingency for a previously disclosed grant of 455,000 "Replacement Options" to Mr. File.
  • Director Elections: Mr. Justin J. File and Mr. Joshua Riezman were elected to the Board of Directors to serve until fiscal year 2029.
  • Executive Compensation: The advisory vote on executive compensation was approved.
  • Auditor Ratification: The appointment of CBIZ CPAs as the independent registered public accounting firm for the fiscal year ending June 30, 2026, was ratified.

Guidance, Outlook, and Risks

The filing contains no forward-looking guidance, management commentary on future outlook, or specific risk factors beyond the standard disclosures inherent in the equity plan and director elections. No unusual items or contingencies were reported other than the satisfaction of the option grant contingency.

Investor Verification Checklist

  • Verify the terms of the 455,000 Replacement Options granted to Mr. File as detailed in the Form 8-K/A filed on November 20, 2025.
  • Review the full text of the 2026 Omnibus Equity Compensation Plan (Exhibit 10.1) for share reserve limits and vesting schedules.
  • Confirm the total number of shares outstanding (36,785,397) and the voting participation rate (19,437,130 shares represented) at the Annual Meeting.
  • Check subsequent filings for the official appointment of CBIZ CPAs for the fiscal year ending June 30, 2026.